146 related articles for article (PubMed ID: 15030529)
1. Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.
Makowski GS; Ramsby ML
Clin Exp Immunol; 2004 Apr; 136(1):176-87. PubMed ID: 15030529
[TBL] [Abstract][Full Text] [Related]
2. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
Makowski GS; Ramsby ML
Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
[TBL] [Abstract][Full Text] [Related]
3. Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.
Makowski GS; Ramsby ML
Inflammation; 1999 Aug; 23(4):333-60. PubMed ID: 10443797
[TBL] [Abstract][Full Text] [Related]
4. Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.
Makowski GS; Ramsby ML
Inflammation; 1998 Dec; 22(6):599-617. PubMed ID: 9824774
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
6. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis.
Tchetverikov I; Lohmander LS; Verzijl N; Huizinga TW; TeKoppele JM; Hanemaaijer R; DeGroot J
Ann Rheum Dis; 2005 May; 64(5):694-8. PubMed ID: 15834054
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
8. Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: implications for atherosclerotic disease.
Makowski GS; Ramsby ML
Inflammation; 2001 Oct; 25(5):319-29. PubMed ID: 11820459
[TBL] [Abstract][Full Text] [Related]
9. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
Cheng PT; Pritzker KP
J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
11. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
[TBL] [Abstract][Full Text] [Related]
13. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee.
Halverson PB; McCarty DJ
Ann Rheum Dis; 1986 Jul; 45(7):603-5. PubMed ID: 3017246
[TBL] [Abstract][Full Text] [Related]
14. An indium:calcium phosphate colloid that specifically targets fibrin.
Makowski GS; Ramsby ML; Ramsby GR
J Biomed Sci; 2005; 12(2):421-9. PubMed ID: 15918002
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
16. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
[TBL] [Abstract][Full Text] [Related]
17. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
Baker EA; Bergin FG; Leaper DJ
Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
